National Science Foundation

CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.

NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

NeuroGeneces utilizes advanced neuroscience, sleep expertise, and artificial intelligence to deliver brain health assessments aimed at enhancing cognitive longevity. The company has received funding from various reputable sources, including government agencies and private investors. Its flagship product is a sleep headband equipped with machine learning algorithms that analyze EEG data, comparing it against a proprietary normative database to determine an individual's biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep patterns, including quantity, quality, and heart rate variability, providing essential support for clinicians focused on wellness and preventative care. By identifying neurodegeneration early, NeuroGeneces aims to empower users to optimize their mental and physical performance.

JelikaLite specializes in developing medical equipment for children with autism spectrum disorders, focusing on non-invasive methods to enhance brain health. Their primary product is a wearable device that integrates infrared light, EEG sensors, and an artificial intelligence personalization platform. This therapeutic device aims to reduce the symptoms of autism by promoting improvements in speech, decreasing anxiety, and enhancing responsiveness in pediatric patients. By utilizing innovative therapies, JelikaLite seeks to provide lasting benefits for children dealing with autism, emphasizing a commitment to advancing pediatric neurological health.

Precision Neuroscopics is a medical device company located in Pittsburgh, Pennsylvania, specializing in the development of advanced high-density electroencephalography (EEG) systems. These innovative systems are designed to non-invasively detect brain signals that indicate worsening traumatic brain injuries. The company's focus is on creating engineering technologies that enhance the density, durability, and usability of brain recording systems. By improving the quality of EEG signal recordings, Precision Neuroscopics aims to assist clinicians in reducing clinical time and costs associated with brain monitoring, ultimately enhancing patient care.

NeuroLogic Solutions, established in 2016 and based in Baltimore, Maryland, develops advanced EEG analytic software aimed at enhancing the diagnosis and treatment of epilepsy. The company’s platform analyzes electroencephalography data to identify regions of the brain affected by seizures, which assists clinicians in diagnosing epilepsy more accurately and guiding surgical interventions. By providing insights that can lead to seizure freedom, NeuroLogic Solutions seeks to improve patient outcomes and contribute to the overall effectiveness of epilepsy care.

Cogwear is a brain technology company focused on addressing the needs of individuals suffering from anxiety and depression. The firm is developing a next-generation wearable device that enhances traditional physical measurements by integrating cognitive and emotional insights. This innovation aims to transition brain monitoring from laboratory settings to everyday life, providing users with real-time access to clinical-grade cognitive and emotional data. Utilizing AI-powered algorithms and proprietary dry electroencephalography (EEG) sensors, the wearable comfortably and accurately measures brain activity. The device captures and analyzes brainwaves, enabling users to receive feedback on their mental state through a secure app and shareable dashboard. By unlocking valuable insights into brain health, Cogwear aspires to improve individual well-being and performance.

Precision Neuroscopics is a medical device company located in Pittsburgh, Pennsylvania, specializing in the development of advanced high-density electroencephalography (EEG) systems. These innovative systems are designed to non-invasively detect brain signals that indicate worsening traumatic brain injuries. The company's focus is on creating engineering technologies that enhance the density, durability, and usability of brain recording systems. By improving the quality of EEG signal recordings, Precision Neuroscopics aims to assist clinicians in reducing clinical time and costs associated with brain monitoring, ultimately enhancing patient care.

NeuroLogic Solutions, established in 2016 and based in Baltimore, Maryland, develops advanced EEG analytic software aimed at enhancing the diagnosis and treatment of epilepsy. The company’s platform analyzes electroencephalography data to identify regions of the brain affected by seizures, which assists clinicians in diagnosing epilepsy more accurately and guiding surgical interventions. By providing insights that can lead to seizure freedom, NeuroLogic Solutions seeks to improve patient outcomes and contribute to the overall effectiveness of epilepsy care.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.